InvestorsHub Logo
Followers 27
Posts 3416
Boards Moderated 0
Alias Born 07/17/2006

Re: None

Friday, 10/16/2015 12:15:12 PM

Friday, October 16, 2015 12:15:12 PM

Post# of 346155
Peregrine management has moved Bavi out of the shadows and into the immunotherapy spotlight. The multiple collaborations, MSK research, and multiple clinical trials are putting Bavi to the test. Only a very confident management would expose their product so confidently. Many of us here believe we have reason to expect Bavi will not disappoint.

Too bad "the market" does not share our assessment. Maybe they will. Maybe soon.

GLTA, Especial Sunrise Bavi-arm Sunrise Patients,

Paul
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News